Important Eye Care News for You!

EYLEA is a New Medicine for the Treatment of Macular Degeneration

Posted by Dr. J. R. Lacey, Therapeutic Optometrist

Jan 14, 2012 8:18:00 PM

Eylea is an Effective Treatment for Macular Degeneration and Costs Less than Current Similar Medicine

EYLEA™ (aflibercept) was approved in December 2011 for the treatment of neovascular (wet) macular degeneration.

Eylea (by Regeneron) works much like Lucentis and Avastin in its treatment of macular degeneration except that it is used less frequently and costs less. The recommended dose for EYLEA is 2 mg (0.05 mL) administered by injection into the vitreous of the eye every 4 weeks (monthly) for the first 3 months followed by 2 mg (0.05 mL) via injection once every 8 weeks (2 months).

Read More

Topics: Avastin, Central Retina, Macular Degeneration Treatment, Lucentis, Macular Degeneration, Macula, Eylea, Aflibercept

About Eye Care News

Eye Care News features important topics regarding eye care health.  Over one-hundred eye care posts have been published, providing our readers with a great resource for timely news about eye care.

Subscribe to Email Updates

Our Most Popular Posts

Posts by Topic

see all

Recent Posts